Funding Opportunities
Funding Opportunities
Pre-proposal due. The Unsolicited Research Program is designed to select and fund pioneering research projects that can significantly advance scientific knowledge and build practical water quality solutions.
LOI due. This program will support multidisciplinary translational research Centers focused on generating, validating, and advancing medical countermeasures against bacteria or fungi listed in the NOFO with known and emerging resistance to current therapies.
Concept paper due. The Water Quality Research Foundation (WQRF) is issuing this request for concept papers (RFCP) under its research grant program.
Strong consideration will be given to projects that involve collaborations and stakeholder engagement, model best practices, can demonstrate measurable outcomes in a one-year timeframe, and share successes broadly. For anything we fund, particularly demonstration projects or place-based work, we prefer opportunities for broader impact through replicating or scaling.
Limited submission, contact research office before applying. Letter of intent due for exceptional project grants and young investigator grants.
The goal of this initiative is to engage and support the careers of promising Black/African American clinical and/or laboratory investigators in the field of multiple myeloma research. The Scholars Program will support the awardee from post-doctoral training to first faculty-track position.
We are looking for bifunctional small molecules that can inhibit target protein function through protein-protein interactions (PPI). We are also looking for a methodology for rationally designing such bifunctional compounds based on protein structural information. (It does not matter whether the target interaction is intracellular or extracellular.)
We are seeking novel chemical derivatives (small molecules or peptides) that can be internalized into a wide range of PDAC cells selectively via unique mechanism of action. We are also interested in screening systems to identify our desired chemical products.
As the nation's largest private, not-for-profit source of funds for scientists studying cancer, the American Cancer Society (ACS) remains committed to funding basic, translational, clinical, and cancer control research now and in the future - as much as we are able given our available financial resources.
Institutional Research Grants (IRG) are awarded to institutions as block grants, providing seed money for newly independent investigators to initiate cancer research projects.